Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Trials & Filings in Brief: January 8, 2014 | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances, Trials & Filings

Trials & Filings in Brief: January 8, 2014

BioMarin, BMS, Catalyst, Merck, NPS, Pacira, Repros, Rexahn

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase I
Rexahn begins solid tumor trial . . . read more

Phase III
Catalyst, BioMarin post positive Firdapse results . . . read more

Repros’ Androxal in head-to-head testosterone trial . . . read more

Phase IV
Exparel performs strongly against IV PCA opioid . . . read more

Filings
EMA accepts HCV MAA from BMS . . . read more

NPS BLA accepted for hypoparathyroidism . . . read more

Approvals
Merck HIV treatment approved in oral suspension . . . read more

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics